🇺🇸 MRK — Merck & Co., Inc.

Salud Compra
← Volver

Precio actual

146,73 USD

Máx. histórico

156,45

73 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-6,21%

Rango 52 semanas

85,24 – 156,92

Variación hoy

-0,14%

Cierre anterior

146,94

Rango de hoy

142,80 – 147,48

Volumen hoy

7.462.267

Peor caída histórica

-68,62%

28/12/2000 → 09/03/2009

Recuperado en 1796 días

Volatilidad anualizada ⓘ

25,43%

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
148,21 (puede no estar actualizado)
Dividend yield
2,31% (puede no estar actualizado)
Precio objetivo analistas
161,53 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,4000 USD · Yield: 2,32%
Fecha de pago Importe por participación
15/09/2026 0,8500 USD
15/06/2026 0,8500 USD
16/03/2026 0,8500 USD
15/12/2025 0,8500 USD
15/09/2025 0,8100 USD
16/06/2025 0,8100 USD
17/03/2025 0,8100 USD
16/12/2024 0,8100 USD
16/09/2024 0,7700 USD
17/06/2024 0,7700 USD
14/03/2024 0,7700 USD
14/12/2023 0,7700 USD
14/09/2023 0,7300 USD
14/06/2023 0,7300 USD
14/03/2023 0,7300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/01/2002 55,92 56,20 54,89 55,34 -1,02% 2,35% 5.840.714
17/01/2002 55,51 56,20 55,42 55,92 +0,64% 1,41% 4.393.950
16/01/2002 56,15 56,56 55,52 55,56 -0,72% 1,87% 4.209.397
15/01/2002 56,77 57,11 55,39 55,96 -0,34% 3,03% 8.557.025
14/01/2002 56,39 57,13 56,15 56,15 -0,22% 1,73% 5.304.138
11/01/2002 56,87 57,11 55,85 56,28 +0,02% 2,21% 5.967.207
10/01/2002 55,73 56,29 55,60 56,27 +0,25% 1,23% 5.461.862
09/01/2002 56,04 56,92 55,92 56,13 +0,15% 1,79% 6.867.544
08/01/2002 55,44 56,04 55,40 56,04 +1,08% 1,15% 7.456.520
07/01/2002 55,76 55,96 55,37 55,44 -1,34% 1,06% 5.809.378
04/01/2002 55,87 56,19 55,30 56,19 -0,24% 1,61% 6.844.383
03/01/2002 57,02 57,02 55,73 56,33 -1,22% 2,28% 8.374.987
02/01/2002 56,44 57,11 55,44 57,02 +1,63% 2,96% 7.540.465
31/12/2001 56,82 56,95 56,07 56,11 -1,21% 1,54% 5.665.069
28/12/2001 56,92 57,18 56,67 56,79 -0,43% 0,89% 4.161.608
27/12/2001 56,32 57,04 56,15 57,04 -0,28% 1,58% 5.380.642
26/12/2001 57,28 57,63 56,83 57,20 -0,13% 1,40% 4.745.763
24/12/2001 56,97 57,39 56,92 57,28 +0,67% 0,82% 2.718.093
21/12/2001 57,44 57,47 56,77 56,90 -0,20% 1,21% 9.449.502
20/12/2001 56,61 57,41 56,00 57,01 +0,71% 2,49% 7.212.022
19/12/2001 55,83 57,25 55,73 56,61 +1,42% 2,73% 10.680.902
18/12/2001 55,33 56,18 54,64 55,82 +2,33% 2,79% 9.670.525
17/12/2001 55,90 56,20 54,20 54,55 -1,58% 3,58% 11.281.930
14/12/2001 55,49 55,72 55,12 55,43 +0,26% 1,07% 8.121.371
13/12/2001 55,87 57,11 54,87 55,29 -0,99% 4,01% 14.345.129
12/12/2001 57,97 57,97 54,86 55,84 -3,59% 5,37% 34.441.577
11/12/2001 64,36 64,46 57,07 57,92 -9,39% 11,48% 21.704.918
10/12/2001 63,60 64,79 63,17 63,92 -0,01% 2,55% 7.368.383
07/12/2001 63,12 63,93 63,08 63,93 +1,29% 1,35% 5.302.356
06/12/2001 63,46 63,93 63,02 63,12 -0,14% 1,43% 5.804.034